🚀 VC round data is live in beta, check it out!
Biome Australia Valuation Multiples
Discover revenue and EBITDA valuation multiples for Biome Australia and similar public comparables like Hofseth BioCare, Enzymatica, Provexis, Vita Life Sciences and more.
Biome Australia Overview
About Biome Australia
Biome Australia Ltd licences, develops, and markets evidence-based, complementary medicines, including nutraceuticals vitamins and weight management products and live biotherapeutics. The company has one operating segment: researching, developing, manufacturing and distributing evidence-based products linking the gut and human health. Domestically it caters to Australia and In international markets, the Group distributes and markets its Activated Probiotics range in the United Kingdom and New Zealand through independent health practitioners.
Founded
2018
HQ
Employees
30
Website
Financials (LTM)
EV
$66M
Biome Australia Financials
Biome Australia reported last 12-month revenue of $17M and EBITDA of $2M.
In the same LTM period, Biome Australia generated $10M in gross profit, $2M in EBITDA, and $2M in net income.
Revenue (LTM)
Biome Australia P&L
In the most recent fiscal year, Biome Australia reported revenue of $13M and EBITDA of $452K.
Biome Australia expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $17M | XXX | $13M | XXX | XXX | XXX |
| Gross Profit | $10M | XXX | $8M | XXX | XXX | XXX |
| Gross Margin | 61% | XXX | 61% | XXX | XXX | XXX |
| EBITDA | $2M | XXX | $452K | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 4% | XXX | XXX | XXX |
| EBIT Margin | 11% | XXX | 2% | XXX | XXX | XXX |
| Net Profit | $2M | XXX | $151K | XXX | XXX | XXX |
| Net Margin | 10% | XXX | 1% | XXX | XXX | XXX |
| Net Debt | — | — | $112K | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Biome Australia Stock Performance
Biome Australia has current market cap of $66M, and enterprise value of $66M.
Market Cap Evolution
Biome Australia's stock price is $0.30.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $66M | $66M | -1.1% | XXX | XXX | XXX | $0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBiome Australia Valuation Multiples
Biome Australia trades at 3.9x EV/Revenue multiple, and 31.9x EV/EBITDA.
EV / Revenue (LTM)
Biome Australia Financial Valuation Multiples
As of March 20, 2026, Biome Australia has market cap of $66M and EV of $66M.
Equity research analysts estimate Biome Australia's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Biome Australia has a P/E ratio of 37.3x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $66M | XXX | $66M | XXX | XXX | XXX |
| EV (current) | $66M | XXX | $66M | XXX | XXX | XXX |
| EV/Revenue | 3.9x | XXX | 5.1x | XXX | XXX | XXX |
| EV/EBITDA | 31.9x | XXX | 146.0x | XXX | XXX | XXX |
| EV/EBIT | 36.1x | XXX | 338.9x | XXX | XXX | XXX |
| EV/Gross Profit | 6.4x | XXX | 8.3x | XXX | XXX | XXX |
| P/E | 37.3x | XXX | 435.6x | XXX | XXX | XXX |
| EV/FCF | 88.9x | XXX | (35.1x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Biome Australia Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Biome Australia Margins & Growth Rates
Biome Australia's revenue in the last 12 month grew by 41%.
Biome Australia's revenue per employee in the last FY averaged $0.6M.
Biome Australia's rule of 40 is 53% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Biome Australia's rule of X is 114% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Biome Australia Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 41% | XXX | 45% | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Growth | 131% | XXX | 508% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 53% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 114% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.6M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 34% | XXX | 24% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 34% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 61% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Biome Australia Public Comps
See public comps and valuation multiples for other Nutraceuticals & Cosmeceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Hofseth BioCare | XXX | XXX | XXX | XXX | XXX | XXX |
| Enzymatica | XXX | XXX | XXX | XXX | XXX | XXX |
| Provexis | XXX | XXX | XXX | XXX | XXX | XXX |
| Vita Life Sciences | XXX | XXX | XXX | XXX | XXX | XXX |
| Valbiotis | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Biome Australia M&A Activity
Biome Australia acquired XXX companies to date.
Last acquisition by Biome Australia was on XXXXXXXX, XXXXX. Biome Australia acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Biome Australia
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialBiome Australia Investment Activity
Biome Australia invested in XXX companies to date.
Biome Australia made its latest investment on XXXXXXXX, XXXXX. Biome Australia invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Biome Australia
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Biome Australia
| When was Biome Australia founded? | Biome Australia was founded in 2018. |
| Where is Biome Australia headquartered? | Biome Australia is headquartered in Australia. |
| How many employees does Biome Australia have? | As of today, Biome Australia has over 30 employees. |
| Is Biome Australia publicly listed? | Yes, Biome Australia is a public company listed on Australian Securities Exchange. |
| What is the stock symbol of Biome Australia? | Biome Australia trades under BIO ticker. |
| When did Biome Australia go public? | Biome Australia went public in 2021. |
| Who are competitors of Biome Australia? | Biome Australia main competitors are Hofseth BioCare, Enzymatica, Provexis, Vita Life Sciences. |
| What is the current market cap of Biome Australia? | Biome Australia's current market cap is $66M. |
| What is the current revenue of Biome Australia? | Biome Australia's last 12 months revenue is $17M. |
| What is the current revenue growth of Biome Australia? | Biome Australia revenue growth (NTM/LTM) is 41%. |
| What is the current EV/Revenue multiple of Biome Australia? | Current revenue multiple of Biome Australia is 3.9x. |
| Is Biome Australia profitable? | Yes, Biome Australia is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Biome Australia? | Biome Australia's last 12 months EBITDA is $2M. |
| What is Biome Australia's EBITDA margin? | Biome Australia's last 12 months EBITDA margin is 12%. |
| What is the current EV/EBITDA multiple of Biome Australia? | Current EBITDA multiple of Biome Australia is 31.9x. |
| What is the current FCF of Biome Australia? | Biome Australia's last 12 months FCF is $742K. |
| What is Biome Australia's FCF margin? | Biome Australia's last 12 months FCF margin is 4%. |
| What is the current EV/FCF multiple of Biome Australia? | Current FCF multiple of Biome Australia is 88.9x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.